Forensic Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Kits, Analyzers & Sequencers, Software, Consumables), By Technique (Capillary Electrophoresis {CE}, Next-generation Sequencing {NGS}, PCR Amplification), By Application (Criminal Testing, Paternity & Familial Testing, Biodefense, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 602.55 Million
CAGR (2026-2031)	15.62%
Fastest Growing Segment	Software
Largest Market	North America
Market Size (2031)	USD 1439.43 Million

Market Overview

The Global Forensic Genomics Market is projected to grow from USD 602.55 Million in 2025 to USD 1439.43 Million by 2031 at a 15.62% CAGR. Forensic genomics involves the application of genomic technologies to legal and criminal investigations, enabling precise identification through DNA analysis from biological material at crime scenes or human remains. The market's growth is primarily driven by the increasing global incidence of criminal activity requiring advanced DNA profiling and human identification capabilities. Furthermore, governmental initiatives to establish and expand national DNA databases significantly bolster demand, alongside continuous advancements in DNA analysis technologies. According to the U.S. Department of Justice, as of 2024, the CODIS database generated over 20 million offender profiles, aiding in more than 600,000 investigations.

Despite these drivers, a significant impediment to market expansion remains the substantial investment required for advanced genomic technologies. The high cost associated with sophisticated equipment, specialized reagents, and complex bioinformatics software can present a considerable barrier for numerous forensic laboratories, particularly in developing regions, thereby hindering broader adoption and implementation.

Key Market Drivers

Advancements in genomic technologies and DNA analysis represent a pivotal force driving the global forensic genomics market. Continuous innovation in sequencing platforms, bioinformatics tools, and DNA profiling techniques enables forensic laboratories to process more challenging samples, including degraded or trace DNA, with greater sensitivity and accuracy. These technological strides also facilitate the adoption of advanced methods like forensic genetic genealogy, which significantly expands the investigative reach for previously unsolvable cases. For instance, according to WLRN, in April 2026, Othram, a Texas-based firm, stated its technology has successfully contributed to solving at least 600 cold cases nationwide. Such capabilities are crucial for human identification, kinship testing, and linking suspects to crime scenes, thereby enhancing the effectiveness of law enforcement and justice systems globally.

Concurrently, growing government initiatives and funding for forensic science are essential for expanding the forensic genomics market's infrastructure and operational capacity. Governments worldwide are increasingly recognizing the value of advanced DNA analysis in crime resolution and public safety, leading to direct investments in technology adoption, database expansion, and specialized training programs. These initiatives often target the reduction of forensic backlogs and the enhancement of investigative tools for complex cases. For example, according to WLRN, in April 2026, the Florida Attorney General announced a $600,000 partnership with a company specializing in matching cold case DNA to genetic genealogy databases. This commitment to funding supports the acquisition of genomic equipment and the development of national and international collaborations. Furthermore, according to Othram, in December 2025, an exhaustive study of 477 identified human remains cases from North America demonstrated successful identifications, underscoring the broader impact of forensic genomic applications supported by such investments.

Download Free Sample Report

Key Market Challenges

A significant impediment to the expansion of the global forensic genomics market is the substantial investment required for advanced genomic technologies. This challenge encompasses the high cost associated with obtaining sophisticated equipment, specialized reagents, and complex bioinformatics software necessary for modern DNA analysis. Such considerable financial outlay presents a formidable barrier for numerous forensic laboratories, particularly those in developing regions or operating with constrained budgets.

The elevated capital expenditure directly hampers the broader adoption and implementation of advanced genomic methods. Laboratories with limited financial resources often struggle to procure the essential instrumentation and maintain ongoing operational expenses, including consumable supplies and software licenses. This situation restricts their ability to upgrade existing capabilities or integrate new genomic techniques, thereby slowing the overall market growth. For instance, according to the Consortium of Forensic Science Organizations (CFSO), in its July 2024 budget brief for Fiscal Year 2025, the U.S. House of Representatives recommended no less than $2,000,000 specifically for high-density sequencing within the $6,000,000 allocated for the National Missing and Unidentified Persons System (NamUs). This limited allocation reflects the funding challenges many jurisdictions face, directly impacting the widespread deployment of precise genomic tools in criminal and legal investigations.

Key Market Trends

The widespread adoption of Next-Generation Sequencing (NGS) in routine casework is fundamentally transforming the capabilities of forensic laboratories. This shift enables more comprehensive and detailed genetic analysis for standard criminal investigations, moving beyond the traditional methods that offer less resolution. NGS allows for the simultaneous analysis of a significantly larger number of genetic markers, providing richer investigative information from even challenging or trace DNA samples. For instance, according to Syracuse University, June 2025, in 'Setting the Standard, Ensuring Justice,' the Kern Regional Crime Lab successfully utilized NGS to analyze over 150 genetic markers from a single evidence sample in a murder investigation, a substantial increase compared to the approximately 24 markers detectable with older techniques.

Concurrently, the integration of artificial intelligence (AI) and bioinformatics for automated interpretation is emerging as a critical trend, addressing the increasing complexity and volume of genomic data generated. AI-powered tools streamline the laborious process of data analysis, enhance the accuracy of DNA mixture deconvolution, and reduce the potential for human error in interpreting complex profiles. This automation is vital for improving laboratory throughput and accelerating case resolution. According to Research.com, April 2026, in '2026 AI, Automation, and the Future of Forensic Science Degree Careers,' 35% of forensic science labs in the U.S. have already begun incorporating AI-driven technologies into their workflows.

Segmental Insights

The Software segment is emerging as the fastest-growing component within the Global Forensic Genomics Market. This rapid expansion is primarily driven by the increasing demand for sophisticated solutions that enhance the precision, efficiency, and reliability of forensic analysis. Software plays a crucial role in managing the growing volume of complex genomic data generated from various forensic techniques, including DNA profiling and next-generation sequencing. It facilitates advanced bioinformatics, automated data interpretation, and AI-driven analysis, which are essential for processing intricate DNA mixtures and degraded samples. Furthermore, the need for seamless data integration with national DNA databases, such as the Combined DNA Index System (CODIS), underscores the importance of robust software solutions to support criminal investigations and ensure data compatibility across different jurisdictions.

Regional Insights

North America holds a prominent position in the Global Forensic Genomics Market due to its well-established forensic infrastructure and robust law enforcement systems. The region has demonstrated early and widespread adoption of advanced genomic technologies, including next-generation sequencing and rapid DNA analysis, enhancing investigative capabilities. Significant government funding, notably through agencies like the Federal Bureau of Investigation (FBI), supports extensive DNA databases such as the Combined DNA Index System (CODIS), which are crucial for criminal investigations. Furthermore, a strong legal framework and strict regulatory systems ensure reliable forensic investigation outcomes, solidifying North America's leadership in this specialized market.

Recent Developments

• In April 2026, Promega Corporation expanded its forensic portfolio through a new distribution agreement with NimaGen, a company specializing in advanced sequencing technologies. This collaboration grants forensic casework laboratories access to NimaGen's IDseek® massively parallel sequencing (MPS) kit portfolio through Promega's established network. The IDseek® line, powered by Reverse Complement PCR (RC-PCR) technology, is designed to meet the high sensitivity and specificity demands of challenging forensic samples, including those with degradation or low quantity. These kits supplement Promega’s existing tools for sample preparation and capillary electrophoresis-based analysis, enhancing capabilities for STR, SNP, microhaplotype, and mitochondrial DNA profiling within the global forensic genomics market.
• In April 2026, the Florida Attorney General's office initiated a partnership with Othram, a company specializing in forensic DNA testing and genetic genealogy. This collaboration aims to resolve long-standing cold cases across the state. Othram will apply its advanced forensic genetic genealogy techniques to generate comprehensive DNA profiles from degraded or limited evidence, providing investigative leads where traditional methods have been exhausted. The initiative initially focused on three specific homicide cases from the 1970s and 1980s, demonstrating a commitment to leveraging innovative genomic technologies to bring resolution to families and enhance public safety within the forensic genomics sector.
• In February 2026, the National Institute of Standards and Technology (NIST) released a new forensic DNA reference material, RM 8043, designed to assist crime laboratories in accurately analyzing challenging genetic evidence. This reference material is the first of its kind to include degraded DNA and mixtures of high-quality DNA from multiple individuals, reflecting common complexities found at crime scenes. The new material will enable forensic laboratories globally to validate their methods and train analysts more effectively, ensuring the reliability of results from complex samples. This breakthrough in standardization supports companies in the forensic genomics market by providing a benchmark for test development and quality control.
• In October 2025, Roche unveiled significant advancements for its Sequencing by Expansion (SBX) technology, which garnered a Guinness World Record for the fastest DNA sequencing technique. Achieved by Broad Clinical Labs in collaboration with Roche Sequencing Solutions and Boston Children's Hospital, a human genome was processed in under four hours. This innovative technology converts DNA into an "Xpandomer" molecule to enhance speed and signal clarity. While initially highlighted for broader genomic research and clinical applications, such rapid and high-throughput sequencing capabilities hold substantial implications for the global forensic genomics market, particularly for urgent investigations and analysis of diverse forensic samples.

Key Market Players

• Illumina, Inc.
• Verogen, Inc.
• Agilent Technologies, Inc.
• Thermo Fischer Scientific, Inc.
• QIAGEN N.V.
• GE Healthcare
• Gene by Gene, Ltd.
• Neogen Corporation
• Eurofins Scientific SE
• Othram Inc.

By Component	By Technique	By Application	By Region
Kits Analyzers & Sequencers Software Consumables	Capillary Electrophoresis {CE} Next-generation Sequencing {NGS} PCR Amplification	Criminal Testing Paternity & Familial Testing Biodefense Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Forensic Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Forensic Genomics Market, By Component:

• Kits
• Analyzers & Sequencers
• Software
• Consumables

• Forensic Genomics Market, By Technique:

• Capillary Electrophoresis {CE}
• Next-generation Sequencing {NGS}
• PCR Amplification

• Forensic Genomics Market, By Application:

• Criminal Testing
• Paternity & Familial Testing
• Biodefense
• Others

• Forensic Genomics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE